Home to
 

Keywords :   


Tag: to

Vacancies in the Apartment Sector Are Slow to Rise

2015-10-06 09:00:00| National Real Estate Investor

Even the most pessimistic apartment market researchers agree that very few apartments were empty in the third quarter and that the vacancy rate in the multifamily rental sector will remain low in the short-term. read more

Tags: to sector slow rise

 

News Advisory: Join Portlands Safe Routes to School Program on Oct. 7 for a celebration of success on International Walk and Bike to School Day

2015-10-06 02:20:11| PortlandOnline

Tags: to news day international

 
 

Weekly Overview: Chinese Tote Bags Thought to Have Brought PEDv to US

2015-10-06 02:00:00| ThePigSite - Industry News

ANALYSIS - An investigation by the USDA has found that Porcine Epidemic Diarrhoea (PED) may have entered the US through reusable containers used to transport bulk material, such as feed or pet food, from China.

Tags: to us thought brought

 

On Leadership: Twitter's new CEO won't get any direct pay to run the company

2015-10-06 00:35:22| Jewelry - Topix.net

Twitter named co-founder and interim Chief Executive Jack Dorsey as its permanent CEO, ending months of speculation about who would take the reins at the company. REUTERS/Mike Blake/Files There are apparently many reasons Twitter's board decided to name Jack Dorsey permanent CEO.

Tags: to the company run

 

Merck Congratulates Awardees of 2015 Nobel Prize in Physiology or Medicine for Discovery Leading to River Blindness Treatment

2015-10-05 23:15:00| Merck.com - Corporate News

Dateline City: KENILWORTH, N.J. Co-recipient Dr. William C. Campbell Conducted his Nobel Prize-winning Work at Merck Research Laboratories KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, proudly congratulates William C. Campbell, a retired scientist from Merck Research Laboratories, who was jointly named the 2015 Nobel Prize winner in Physiology or Medicine with Satoshi Omura for the discovery of avermectin, which led to Mercks development of Mectizan (ivermectin), a treatment for river blindness (also known as onchocerciasis) in Africa, Latin America and Yemen. Language: English Contact: MerckMedia:Lainie Keller, 908-236-5036orClaire Gillespie, 267-305-0932orInvestors:Terri Loxam, 908-740-1986orJustin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more

Tags: to treatment leading river

 

Sites : [1127] [1128] [1129] [1130] [1131] [1132] [1133] [1134] [1135] [1136] [1137] [1138] [1139] [1140] [1141] [1142] [1143] [1144] [1145] [1146] next »